.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
UBS
Federal Trade Commission
McKinsey
Moodys
QuintilesIMS
Cerilliant
Baxter
Chinese Patent Office
Medtronic

Generated: November 17, 2017

DrugPatentWatch Database Preview

CEFADYL Drug Profile

« Back to Dashboard

What is the patent landscape for Cefadyl, and when can generic versions of Cefadyl launch?

Cefadyl is a drug marketed by Apothecon and is included in four NDAs.

The generic ingredient in CEFADYL is cephapirin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephapirin sodium profile page.

Medical Subject Heading (MeSH) Categories for CEFADYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION062724-001Dec 23, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION050446-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION050446-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION061769-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION062961-002Sep 20, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION061769-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION062724-002Dec 23, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION050446-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION050446-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEFADYL
cephapirin sodium
INJECTABLE;INJECTION050446-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Novartis
Chubb
Fish and Richardson
QuintilesIMS
Harvard Business School
McKesson
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot